 BioSig Technologies Inc announced that it has agreed to sell 3 million of its common stock and warrants to a family office, which the company said has deep expertise in small-cap emerging growth investing. BioSig noted the net proceeds from the offering will be used to fund working capital and continue commercialization activities related to the PURE EP System. 